Anna Ryabets-Lienhard
Emergency Medicine · Los Angeles, CANPI 1568758548
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $9,328 of the $15,509 with a category attached, or 60.1%. Biomarin Pharmaceutical Inc. accounts for 64.9% of it on its own, with 8 other manufacturers making up the rest. Among emergency medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 30 payments — averaging $516.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$10K
- Kyowa Kirin, Inc.$2K
- Ascendis Pharma Endocrinology Inc$2K
- AstraZeneca$1K
- Novo Nordisk$90
- Pfizer$36
- plus $77 from 3 others
Across 396 payments — averaging $7456.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ultragenyx Pharmaceutical Inc.$1.8M
- Amgen$1M
- Biomarin Pharmaceutical Inc.$53K
- Ascendis Pharma Endocrinology Inc$49K
- Takeda Pharmaceuticals U.S.A., Inc.$29K
- Shire North American Group Inc$2K
What the payments were for
- Consulting fees$5,33434%
- Speaking & faculty fees$9,32860%
- Food & beverage$6264%
- Education$2221%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 12 | $10,066 |
| Kyowa Kirin, Inc. | 4 | $2,489 |
| Ascendis Pharma Endocrinology Inc | 5 | $1,626 |
| AstraZeneca | 1 | $1,125 |
| Novo Nordisk | 3 | $90 |
| Pfizer | 2 | $36 |
| Azurity Pharmaceuticals, Inc. | 1 | $27 |
| Tolmar, Inc. | 1 | $26 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VOXZOGO 1.2mg$3,675
- CRYSVITA$2,435
- Strensiq$1,125
- Vimizim$107
How this compares
$15,509 in reported general payments places this provider in the 95th percentile of 6,006 emergency medicine providers in California.
Other emergency medicine in Los Angeles
- Christopher PeabodyLos Angeles$163K
- Samuel BeckermanLos Angeles$81K
- Bharat KothakotaLos Angeles$51K
- Jay LeeLos Angeles$20K
- Michael BlueLone Pine$915K
- Andrew AccardiEncinitas$383K
- Fredrick Melik-AbrahamianSylmar$354K
- Graham WalkerStanford$309K
- Douglas WhiteOakland$220K
- Paul PearigenSan Diego$208K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.